IRVINE, Calif.--(BUSINESS WIRE)--June 1, 2006--In what continues to be an increasingly contentious public policy issue, PrimeCell(TM) Therapeutics, a privately-held biotechnology company, today announced that its Vice President of Research and Development, Francisco Silva, will be available to comment on how the company’s PrimeCell technology could expedite the movement from stem cell research to therapy.
